Lexicon Pharmaceuticals | 税前利润



金融业
股票价格
USD
资产
USD 225.58M
现金及等价物
USD 21.36M
销售成本
USD 17.81M
流动资产
USD 145.08M
流动负债
USD 34.84M
债务
USD 99.27M
股息收益率
0
EBIT
USD -49.63M
EBITDA
USD -49.48M
员工
285
EPS每股收益
USD -0.17
股本和储备
USD 129.44M
销售毛利
USD -16.16M
债务利息支出
USD 2.21M
贷款资金
USD 56.11M
市值
USD 306.6M
净收入
USD -53.43M
营业费用
USD 57M
营业利润
USD -55.35M
普通股股本
USD 245K
PE价格收益
12.44
税前利润
USD -53.43M
销售收入
USD 1.65M
销售和管理费用
USD 39.19M
股票
USD 168K
贸易债权人
USD 5.9M
应收帐款人
USD 2.62M


税前利润 更改 日
Abbott USD 2.36B 178M 2025-12
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Akebia Therapeutics USD 6.11M 28.92M 2025-03
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
AstraZeneca USD 3.24B 117M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Coherus Biosciences USD -47.4M 14.9M 2025-03
Eli Lilly USD 7.23B 456M 2025-09
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Illumina USD 220M 86M 2025-09
Insmed USD -368.7M 48.26M 2025-09
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
J&J USD 4.97B 2.53B 2025-12
Lexicon Pharmaceuticals USD -53.43M 5.03M 2024-06
MacroGenics USD 16.82M 52.97M 2025-09
MannKind USD 7.78M 6.84M 2025-09
Merck USD 6.74B 22M 2025-09
Moderna USD -187M 631M 2025-09
Novartis USD 4.2B 335M 2025-09
PTC Therapeutics USD -23.07M 47.98M 2025-09
Puma Biotechnology USD 20.61M 24.76M 2024-09
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Ultragenyx Pharmaceutical USD -179.54M 65.54M 2025-09
United Therapeutics USD 438M 29.6M 2025-09
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12


Lexicon Pharmaceuticals 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.